EE574 Innovative Mechanisms of Pre-Market Authorization Access for Rare Diseases in Brazil. a Case Study of Pabinafusp-Alfa for Mucopolysaccharidosis Type II
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.2552
https://www.valueinhealthjournal.com/article/S1098-3015(23)02742-0/fulltext
Section Title :
Section Order :
10341
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02742-0&doi=10.1016/j.jval.2023.03.2552